Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.08 | -0.44 | -0.88 |
| FCF Yield | 3.47% | 0.59% | 2.15% | -0.53% |
| EV / EBITDA | -38.36 | 26.61 | 20.91 | 19.01 |
| Quality | ||||
| ROIC | 2.60% | 0.01% | 2.07% | 2.66% |
| Gross Margin | 40.53% | 47.60% | 42.88% | 44.05% |
| Cash Conversion Ratio | -0.97 | 0.76 | 1.80 | 1.06 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.88% | 4.78% | 3.10% | 1.54% |
| Free Cash Flow Growth | 224.84% | -71.26% | 634.36% | -122.83% |
| Safety | ||||
| Net Debt / EBITDA | -13.16 | 5.81 | 4.12 | 4.70 |
| Interest Coverage | 3.44 | 0.02 | 5.64 | 4.50 |
| Efficiency | ||||
| Inventory Turnover | 0.71 | 0.61 | 0.75 | 0.62 |
| Cash Conversion Cycle | 107.95 | 125.25 | 134.92 | 118.12 |